Characterization of CXCR4-using HIV-1 during primary infection by ultra-deep pyrosequencing

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 12, 2013, Pages 2875-2881

  Raymond, Stéphanie ^a,b,c   Saliou, Adrien ^a   Nicot, Florence ^a,c   Delobel, Pierre ^a,b,c   Dubois, Martine ^a,c   Carcenac, Romain ^c   Sauné, Karine ^a,b,c   Marchou, Bruno ^c   Massip, Patrice ^c   Izopet, Jacques ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c CHU PURPAN   (France)

Author keywords

Chemokine receptor; Hiv envelope protein gp120; Hiv quasispecies; Hiv tropism; V3 genotype

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4;

ADULT; ALGORITHM; ARTICLE; CLINICAL ARTICLE; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PHENOTYPE; PRIMARY INFECTION; PYROSEQUENCING; SCREENING; ULTRA DEEP PYROSEQUENCING; VIRAL TROPISM; VIRUS DETECTION;

CHEMOKINE RECEPTOR; HIV ENVELOPE PROTEIN GP120; HIV QUASISPECIES; HIV TROPISM; V3 GENOTYPE;

ADULT; FEMALE; GENETIC VARIATION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; MALE; RECEPTORS, CXCR4; RECEPTORS, HIV; RNA, VIRAL; VIRAL TROPISM; YOUNG ADULT;

EID: 84887521069     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt290     Document Type: Article

References (34)

1. Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease. Annu Rev Immunol 1999; 17: 657-700.
2. Lin NH, Kuritzkes DR. Tropism testing in the clinicalmanagement of HIV-1 infection. Curr Opin HIVAIDS 2009; 4: 481-7.
3. Kootstra NA, Schuitemaker H. Determination of cell tropism of HIV-1. Methods Mol Biol 2005; 304: 317-25.
4. Raymond S, Delobel P, Mavigner M et al. Development and performance of a new recombinant virus phenotypic entry assay to determine HIV-1 coreceptor usage. J Clin Virol 2010; 47: 126-30.
5. Whitcomb JM, Huang W, Fransen S et al. Development and characterization of a novel single-cycle recombinant-virus assay to determine human immunodeficiency virus type 1 coreceptor tropism. Antimicrob Agents Chemother 2007; 51: 566-75.
6. Briggs DR, Tuttle DL, Sleasman JWet al. Envelope V3 amino acid sequence predictsHIV-1phenotype(co-receptorusageandtropismformacrophages). AIDS 2000; 14: 2937-9.
7. Fouchier RA, Groenink M, Kootstra NA et al. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J Virol 1992; 66: 3183-7.
8. Archer J, Braverman MS, Taillon BE et al. Detection of low-frequency pretherapy chemokine (CXC motif) receptor 4 (CXCR4)-using HIV-1 with ultra-deep pyrosequencing. AIDS 2009; 23: 1209-18.
9. Tsibris AM, Korber B, Arnaout R et al. Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo. PloS One 2009; 4: e5683.
10. Swenson LC, Mo T, Dong WW et al. Deep sequencing to infer HIV-1 co-receptor usage: application to three clinical trials of maraviroc in treatment-experienced patients. J Infect Dis 2011; 203: 237-45.
11. Moore JP, Kitchen SG, Pugach P et al. The CCR5 and CXCR4 coreceptors-central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 2004; 20: 111-26.
12. Markowitz M, Mohri H, Mehandru S et al. Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report. Lancet 2005; 365: 1031-8.
13. Schuitemaker H, Koot M, Kootstra NA et al. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J Virol 1992; 66: 1354-60.
14. Yu XF, Wang Z, Vlahov D et al. Infection with dual-tropic human immunodeficiency virus type 1 variants associated with rapid total T cell decline and disease progression in injection drug users. J Infect Dis 1998; 178: 388-96.
15. De Mendoza C, Rodriguez C, Garcia F et al. Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance. J Antimicrob Chemother 2007; 59: 698-704.
16. Eshleman SH, Husnik M, Hudelson S et al. Antiretroviral drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection. AIDS 2007; 21: 1165-74.
17. Frange P, Galimand J, Goujard C et al. High frequency of X4/DM-tropic viruses in PBMC samples from patients with primary HIV-1 subtype-B infection in 1996-2007: the French ANRS CO06 PRIMO Cohort Study. J Antimicrob Chemother 2009; 64: 135-41.
18. Raymond S, Delobel P, Mavigner M et al. CXCR4-using viruses in plasma and peripheral blood mononuclear cells during primary HIV-1 infection and impact on disease progression. AIDS 2010; 24: 2305-12.
19. Shepherd JC, Jacobson LP, Qiao W et al. Emergence and persistence of CXCR4-tropic HIV-1 in a population of men from the Multicenter AIDS Cohort Study. J Infect Dis 2008; 198: 1104-12.
20. Liu R, PaxtonWA, Choe S et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996; 86: 367-77.
21. Schols D, Struyf S, Van Damme J et al. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J Exp Med 1997; 186: 1383-8.
22. Saliou A, Delobel P, Dubois M et al. Concordance between two phenotypic assays and ultradeep pyrosequencing for determining HIV-1 tropism. Antimicrob Agents Chemother 2011; 55: 2831-6.
23. Raymond S, Saliou A, Nicot F et al. Frequency of CXCR4-using viruses in primary HIV-1 infections using ultra-deep pyrosequencing. AIDS 2011; 25: 1668-70.
24. Nischalke HD, Nattermann J, LichterfeldMet al. Rapid determination of the Delta32 deletion in the human CC-chemokine receptor 5 (CCR5) gene without DNA extraction by LightCycler real-time polymerase chain reaction. AIDS Res Hum Retroviruses 2004; 20: 750-4.
25. Delobel P, Nugeyre MT, Cazabat M et al. Population-based sequencing of the V3 region of env for predicting the coreceptor usage of human immunodeficiency virus type 1 quasispecies. J Clin Microbiol 2007; 45: 1572-80.
26. Chesebro B, Wehrly K, Nishio J et al. Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes. J Virol 1996; 70: 9055-9.
27. Groenink M, Andeweg AC, Fouchier RA et al. Phenotype-associated env gene variation among eight related human immunodeficiency virus type 1 clones: evidence for in vivo recombination and determinants of cytotropism outside the V3 domain. J Virol 1992; 66: 6175-80.
28. Huang W, Toma J, Fransen S et al. Coreceptor tropism can be influenced by amino acid substitutions in the gp41 transmembrane subunit of human immunodeficiency virus type 1 envelope protein. J Virol 2008; 82: 5584-93.
29. Laurichesse JJ,Taieb A,Capoulade-MetayCet al. Is long-termvirological response related to CCR5 Delta32 deletion in HIV-1-infected patients started on highly active antiretroviral therapy? HIV Med 2010; 11: 239-44.
30. Martinson JJ, Chapman NH, Rees DC et al. Global distribution of the CCR5 gene 32-basepair deletion. Nat Genet 1997; 16: 100-3.
31. Chalmet K, Dauwe K, Foquet L et al. Presence of CXCR4-using HIV-1 in patients with recently diagnosed infection: correlates and evidence for transmission. J Infect Dis 2012; 205: 174-84.
32. Simon B, Grabmeier-Pfistershammer K, Rieger A et al. HIV coreceptor tropism in antiretroviral treatment-naive patients newly diagnosed at a late stage of HIV infection. AIDS 2010; 24: 2051-8.
33. Ghosn J, Galimand J, Raymond S et al. X4 tropic multi-drug resistant quasi-species detected at the time of primary HIV-1 infection remain exclusive or at least dominant far from PHI. PLoS One 2011; 6: e23301.
34. Hayman A, Moss T, Arnold C et al. Disease progression in heterosexual patients infected with closely related subtype B strains of HIV type 1 with differing coreceptor usage properties. AIDS Res Hum Retroviruses 2004; 20: 365-71.